Eman Simbawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eman Simbawa has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Najwa Al-Johani
Department of Mathematics, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2 shared publicationsSamia Aboushoushah
King Abdulaziz Univ, Fac Sci, Phys Dept, Jeddah 21589, Saudi Arabia
2 shared publicationsHala Abosamra
King Abdulaziz Univ, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia
1 shared publicationJawaher Aljohani
King Abdulaziz Univ, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia
1 shared publicationSalma Al-Tuwairqi
King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah 21589, Saudi Arabia
1 shared publication- Salma M. Al-Tuwairqi
King Abdulaziz University
1 shared publication
Latest Publications
- Open Access
- 1 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0320327
A machine learning computational approach for the mathematical anthrax disease system in animals
Objectives: The current research investigations present the numerical solutions of the anthrax disease system in animals by designing a machine learning stochastic procedure. The mathematical anthrax disease system in animals is classified into susceptible, infected, recovered and vaccinated. Method: A Runge-Kutta solver is applied to collect the dataset, which decreases the mean square error by dividing into training as 78%, testing 12% and verification 10%. The proposed stochastic computing technique is performed through the logistic sigmoid activation function, and a single hidden layer construction, twenty-seven numbers of neurons, and optimization through the Bayesian regularization for the mathematical anthrax disease system in animals. Finding: The designed procedure’s correctness is authenticated through the results overlapping and reducible absolute error, which are calculated around 10-05 to 10-08 for each case of the model. The best training performances are performed as 10-10 to 10-12 of the model. Moreover, the statistical performances in terms of regression coefficient, error histogram, and state transition values enhance the reliability of the proposed stochastic machine learning approach. Novelty: The designed scheme is not applied before to get the numerical results of the anthrax disease system in animals.
- 1 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (4) , e0320327
Open AccessA machine learning computational approach for the mathematical anthrax disease system in animals
Objectives: The current research investigations present the numerical solutions of the anthrax disease system in animals by designing a machine learning stochastic procedure. The mathematical anthrax disease system in animals is classified into susceptible, infected, recovered and vaccinated. Method: A Runge-Kutta solver is applied to collect the dataset, which decreases the mean square error by dividing into training as 78%, testing 12% and verification 10%. The proposed stochastic computing technique is performed through the logistic sigmoid activation function, and a single hidden layer construction, twenty-seven numbers of neurons, and optimization through the Bayesian regularization for the mathematical anthrax disease system in animals. Finding: The designed procedure’s correctness is authenticated through the results overlapping and reducible absolute error, which are calculated around 10-05 to 10-08 for each case of the model. The best training performances are performed as 10-10 to 10-12 of the model. Moreover, the statistical performances in terms of regression coefficient, error histogram, and state transition values enhance the reliability of the proposed stochastic machine learning approach. Novelty: The designed scheme is not applied before to get the numerical results of the anthrax disease system in animals.
- Open Access
- 1 January 2021
- Published by SCIK Publishing Corporation in Communications in Mathematical Biology and Neuroscience
- Vol. 2021
Logistic growth model and modified versions for the cumulative number of confirmed cases of COVID-19 in Saudi Arabia
In this study, mathematical modeling is applied to investigate the epidemiology of COVID-19 in Saudi Arabia. The aim was to estimate the cumulative number of infected cases using a logistic growth function and three modified models. The daily cumulative number of confirmed cases was collected from the online COVID-19 dashboard provided by the Ministry of Health. The period covered in this study began from 2nd March until the 20th August 2020. Data was fitted to the logistic growth function and three modified versions by using an online tool which implements the least squares estimate method. The results show all models fit significantly. The predictions from all these models are very similar and encouraging. According to the results the growth rate should decline from approximately 21st Jun 2020 onwards and the maximum number of cumulative confirmed infected cases in Saudi Arabia would be around 324,000 predicting an end to the pandemic by April 2021.
- 1 January 2021
- Published by SCIK Publishing Corporation in Communications in Mathematical Biology and Neuroscience
- Vol. 2021
Open AccessLogistic growth model and modified versions for the cumulative number of confirmed cases of COVID-19 in Saudi Arabia
In this study, mathematical modeling is applied to investigate the epidemiology of COVID-19 in Saudi Arabia. The aim was to estimate the cumulative number of infected cases using a logistic growth function and three modified models. The daily cumulative number of confirmed cases was collected from the online COVID-19 dashboard provided by the Ministry of Health. The period covered in this study began from 2nd March until the 20th August 2020. Data was fitted to the logistic growth function and three modified versions by using an online tool which implements the least squares estimate method. The results show all models fit significantly. The predictions from all these models are very similar and encouraging. According to the results the growth rate should decline from approximately 21st Jun 2020 onwards and the maximum number of cumulative confirmed infected cases in Saudi Arabia would be around 324,000 predicting an end to the pandemic by April 2021.
- Open Access
- 13 April 2020
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2020, 1-10
Modeling the Spatiotemporal Dynamics of Oncolytic Viruses and Radiotherapy as a Treatment for Cancer
Virotherapy is a novel treatment for cancer, which may be delivered as a single agent or in combination with other therapies. Research studies indicated that the combination of viral therapy and radiation therapy has synergistic antitumor effects in in vitro and in vivo. In this paper, we proposed two models in the form of partial differential equations to investigate the spatiotemporal dynamics of tumor cells under virotherapy and radiovirotherapy. We first presented a virotherapy model and solved it numerically for different values of the parameters related to the oncolytic virus, which is administered continuously. The results showed that virotherapy alone cannot eradicate cancer, and thus, we extended the model to include the effect of radiotherapy in combination with virotherapy. Numerical investigations were carried out for three modes of radiation delivery which are constant, decaying, and periodic. The numerical results showed that radiovirotherapy leads to complete eradication of the tumor provided that the delivery of radiation is constant. Moreover, there is an optimal timing for administering radiation, as well as an ideal dose that improves the results of the treatment. The virotherapy in our model is given continuously over a certain period of time, and bolus treatment (where virotherapy is given in cycles) could be considered and compared with our results.
- 13 April 2020
- Published by Hindawi Limited in Computational and Mathematical Methods in Medicine
- Vol. 2020, 1-10
Open AccessModeling the Spatiotemporal Dynamics of Oncolytic Viruses and Radiotherapy as a Treatment for Cancer
Virotherapy is a novel treatment for cancer, which may be delivered as a single agent or in combination with other therapies. Research studies indicated that the combination of viral therapy and radiation therapy has synergistic antitumor effects in in vitro and in vivo. In this paper, we proposed two models in the form of partial differential equations to investigate the spatiotemporal dynamics of tumor cells under virotherapy and radiovirotherapy. We first presented a virotherapy model and solved it numerically for different values of the parameters related to the oncolytic virus, which is administered continuously. The results showed that virotherapy alone cannot eradicate cancer, and thus, we extended the model to include the effect of radiotherapy in combination with virotherapy. Numerical investigations were carried out for three modes of radiation delivery which are constant, decaying, and periodic. The numerical results showed that radiovirotherapy leads to complete eradication of the tumor provided that the delivery of radiation is constant. Moreover, there is an optimal timing for administering radiation, as well as an ideal dose that improves the results of the treatment. The virotherapy in our model is given continuously over a certain period of time, and bolus treatment (where virotherapy is given in cycles) could be considered and compared with our results.
- Open Access
- 1 January 2020
- Published by SCIK Publishing Corporation in Communications in Mathematical Biology and Neuroscience
- Vol. 2020
MATHEMATICAL MODEL OF IMMUNOTHERAPY RESPONSE TO ANTIBODIES AS A TREATMENT FOR CANCER
Immunotherapy is a significant cancer treatment as it uses the body's natural immune system to fight cancer. To help boost the immune system, monoclonal antibodies (MABs) are used as they bind to cancer cells helping the immune system recognize these cells. In this paper, we present a mathematical model of nonlinear partial differential equations describing the interaction between the immune cells, MABs, and cancer cells. After nondimensionalizing the model, we analyzed the long-term behavior and found later that it is consistent with the numerical results. Then, we calculated the numerical solutions of the model with different values of the parameters (relative growth rate of cancer cells and the number of immune cells that are removed after killing a cancer cell) to determine the values that help increase the effectiveness of the treatment. We have considered the continuous delivery of antibodies over a certain period of time. These simulations showed that immune cells will eradicate cancer if the number of immune cells that are removed after killing a cancer cell is less than one. However, if each immune cell kills only one cancer cell, then the treatment reduces the cancer to a steady state or almost a steady state. On the other hand, if the relative growth rate of cancer cells is very small and each cancer cell needs more than one immune cell to kill it, then again, we get a steady state for cancer. However, if the relative growth rate is not small, then the cancer will grow after an initial decrease. This study could be implemented into a clinical trial with different delivery protocols of the drug to improve cancer treatment.
- 1 January 2020
- Published by SCIK Publishing Corporation in Communications in Mathematical Biology and Neuroscience
- Vol. 2020
Open AccessMATHEMATICAL MODEL OF IMMUNOTHERAPY RESPONSE TO ANTIBODIES AS A TREATMENT FOR CANCER
Immunotherapy is a significant cancer treatment as it uses the body's natural immune system to fight cancer. To help boost the immune system, monoclonal antibodies (MABs) are used as they bind to cancer cells helping the immune system recognize these cells. In this paper, we present a mathematical model of nonlinear partial differential equations describing the interaction between the immune cells, MABs, and cancer cells. After nondimensionalizing the model, we analyzed the long-term behavior and found later that it is consistent with the numerical results. Then, we calculated the numerical solutions of the model with different values of the parameters (relative growth rate of cancer cells and the number of immune cells that are removed after killing a cancer cell) to determine the values that help increase the effectiveness of the treatment. We have considered the continuous delivery of antibodies over a certain period of time. These simulations showed that immune cells will eradicate cancer if the number of immune cells that are removed after killing a cancer cell is less than one. However, if each immune cell kills only one cancer cell, then the treatment reduces the cancer to a steady state or almost a steady state. On the other hand, if the relative growth rate of cancer cells is very small and each cancer cell needs more than one immune cell to kill it, then again, we get a steady state for cancer. However, if the relative growth rate is not small, then the cancer will grow after an initial decrease. This study could be implemented into a clinical trial with different delivery protocols of the drug to improve cancer treatment.
- Open Access
- 1 January 2019
- Published by SCIK Publishing Corporation in Communications in Mathematical Biology and Neuroscience
- Vol. 2019
Modeling the spatiotemporal dynamics of virotherapy and immune response as a treatment for cancer
Modeling the spatiotemporal dynamics of virotherapy and immune response as a treatment for cancer
- 1 January 2019
- Published by SCIK Publishing Corporation in Communications in Mathematical Biology and Neuroscience
- Vol. 2019
Open AccessModeling the spatiotemporal dynamics of virotherapy and immune response as a treatment for cancer
Modeling the spatiotemporal dynamics of virotherapy and immune response as a treatment for cancer
- Open Access
- 27 August 2017
- Published by Wiley in Computational and Mathematical Methods in Medicine
- Vol. 2017, 1-7
Mechanistic Model for Cancer Growth and Response to Chemotherapy
Cancer treatment has developed over the years; however not all patients respond to this treatment, and therefore further research is needed. In this paper, we employ mathematical modeling to understand the behavior of cancer and its interaction with therapy. We study a drug delivery and drug-cell interaction model along with cell proliferation. Due to the fact that cancer cells grow when there are enough nutrients and oxygen, proliferation can be a barrier against a response to therapy. To understand the effect of this factor, we perform numerical simulations of the model for different values of the parameters with a continuous delivery of the drug. The numerical results showed that cancer dies after short apoptotic cycles if the cancer is highly vascularized or if the penetration of the drug is high. This suggests promoting angiogenesis or perfusion of the drug. This result is similar to the situation where proliferation is not considered since the constant release of drug overcomes the growth of the cells and thus the effect of proliferation can be neglected.
- 27 August 2017
- Published by Wiley in Computational and Mathematical Methods in Medicine
- Vol. 2017, 1-7
Open AccessMechanistic Model for Cancer Growth and Response to Chemotherapy
Cancer treatment has developed over the years; however not all patients respond to this treatment, and therefore further research is needed. In this paper, we employ mathematical modeling to understand the behavior of cancer and its interaction with therapy. We study a drug delivery and drug-cell interaction model along with cell proliferation. Due to the fact that cancer cells grow when there are enough nutrients and oxygen, proliferation can be a barrier against a response to therapy. To understand the effect of this factor, we perform numerical simulations of the model for different values of the parameters with a continuous delivery of the drug. The numerical results showed that cancer dies after short apoptotic cycles if the cancer is highly vascularized or if the penetration of the drug is high. This suggests promoting angiogenesis or perfusion of the drug. This result is similar to the situation where proliferation is not considered since the constant release of drug overcomes the growth of the cells and thus the effect of proliferation can be neglected.